Cardiologists have warned of the need to monitor for cardiac complications of hydroxychloroquine if it is used as a treatment for COVID-19 disease. As Australia starts clinical trials of the drug and the government approves off label use of hydroxychloroquine for COVID-19, clinicians in France say they found the arrhythmia risks of the drug to ...
Beware of cardiac toxicity with hydroxychloroquine used in COVID-19: cardiologist
By Michael Woodhead
8 Apr 2020